P2.14-63 Cost Analysis of the Management of CNS Metastases in Patients with Advanced ALK+ NSCLC: Alectinib Vs CrizotinibB. Massuti,M. Lazaro,D. Isla, R. Gordo,L. Ruiz De Alda, N. Ortega,I. OyaguezJOURNAL OF THORACIC ONCOLOGY(2019)引用 0|浏览30AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要